HC Wainwright Reiterates “Buy” Rating for Aquestive Therapeutics (NASDAQ:AQST)
HC Wainwright reissued their buy rating on shares of Aquestive Therapeutics (NASDAQ:AQST – Free Report) in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a $10.00 price objective on the stock. Other equities research analysts have also issued reports about the company. Alliance Global Partners reaffirmed a “buy” rating on shares […]
HC Wainwright reissued their buy rating on shares of Aquestive Therapeutics (NASDAQ:AQST – Free Report) in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a $10.00 price objective on the stock. Other equities research analysts have also issued reports about the company. Alliance Global Partners reaffirmed a “buy” rating on shares […]
